NO20055448L - Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon - Google Patents

Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon

Info

Publication number
NO20055448L
NO20055448L NO20055448A NO20055448A NO20055448L NO 20055448 L NO20055448 L NO 20055448L NO 20055448 A NO20055448 A NO 20055448A NO 20055448 A NO20055448 A NO 20055448A NO 20055448 L NO20055448 L NO 20055448L
Authority
NO
Norway
Prior art keywords
antidepressant
depression
treatment
combination
modafinil
Prior art date
Application number
NO20055448A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055448D0 (no
Inventor
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20055448D0 publication Critical patent/NO20055448D0/no
Publication of NO20055448L publication Critical patent/NO20055448L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20055448A 2003-05-13 2005-11-17 Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon NO20055448L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46994403P 2003-05-13 2003-05-13
US10/844,135 US20040242698A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations
PCT/US2004/015198 WO2004100939A1 (fr) 2003-05-13 2004-05-13 Combinaison de modafinil analeptique et d'antidepressifs pour traiter la depression

Publications (2)

Publication Number Publication Date
NO20055448D0 NO20055448D0 (no) 2005-11-17
NO20055448L true NO20055448L (no) 2006-02-01

Family

ID=33457162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055448A NO20055448L (no) 2003-05-13 2005-11-17 Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon

Country Status (14)

Country Link
US (1) US20040242698A1 (fr)
EP (1) EP1633338A1 (fr)
JP (1) JP2007523052A (fr)
KR (1) KR20060023122A (fr)
AR (1) AR047715A1 (fr)
AU (1) AU2004238381A1 (fr)
BR (1) BRPI0411175A (fr)
CA (1) CA2525526A1 (fr)
EA (1) EA200501803A1 (fr)
IS (1) IS8098A (fr)
MX (1) MXPA05012145A (fr)
NO (1) NO20055448L (fr)
TW (1) TW200505426A (fr)
WO (1) WO2004100939A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20080171750A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation Of Neurogenesis With Use of Modafinil
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US9801865B2 (en) * 2008-09-24 2017-10-31 The United States Of America As Represented By The Department Of Veteran Affairs Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
US11260050B2 (en) 2017-02-16 2022-03-01 United States Government As Represented By The Department Of Veterans Affairs Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
WO2001013921A1 (fr) * 1999-08-23 2001-03-01 Ockert David M Tritherapie pour symptomes de sevrage dans le cas des narcotiques et de l'alcool
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
JP2007523052A (ja) 2007-08-16
TW200505426A (en) 2005-02-16
EA200501803A1 (ru) 2006-06-30
AU2004238381A1 (en) 2004-11-25
NO20055448D0 (no) 2005-11-17
WO2004100939A1 (fr) 2004-11-25
KR20060023122A (ko) 2006-03-13
CA2525526A1 (fr) 2004-11-25
WO2004100939B1 (fr) 2007-03-01
US20040242698A1 (en) 2004-12-02
AR047715A1 (es) 2006-02-15
BRPI0411175A (pt) 2006-07-18
MXPA05012145A (es) 2006-02-08
IS8098A (is) 2005-10-27
EP1633338A1 (fr) 2006-03-15

Similar Documents

Publication Publication Date Title
NO20055448L (no) Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon
NO20055450L (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
EA200700333A1 (ru) Терапевтические применения ингибиторов rtp801
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
ECSP077280A (es) Moduladores de quinasa de pirrolo-piridina
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
DK1505990T3 (da) Fremgangsmåder til behandling af hepatitis
CY1111285T1 (el) Θεραπεια αυτοανοσων ασθενειων
MY135829A (en) Analeptic and drug combinations
DK1694354T3 (da) Fremgangsmåde til at forhindre og behandle diabetes ved anvendelse af neurturin
AR054435A1 (es) Agente para profilaxis o terapia contra la depresion o desorden de ansiedad
JOP20210245A1 (ar) طرق لعلاج الداء النشواني من النوع خفيف السلسلة
TW200509895A (en) Analeptic and antidepressant combinations
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
TW200509894A (en) Analeptic and antidepressant combinations
DK1610864T3 (da) Elektromagnetisk stimulering af patienter med osteoporose
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
BRPI0519807A2 (pt) uso de um canal trpc para o tratamento de uma doença cardiovascular
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
SE0003126D0 (sv) Method of treatment
EA202192751A1 (ru) Композиции и способы для лечения потери слуха